arrow_back Civic Audit
Share share

Designating February 28, 2026, as Rare Disease Day

This resolution officially recognizes a day to raise awareness for the millions of people living with rare conditions. It aims to improve diagnosis and encourage the development of new medical treatments.
Key points
Designates February 28, 2026, as Rare Disease Day.
Promotes better awareness and earlier diagnosis for patients.
Supports national and global research for effective cures.
Highlights the need for more FDA-approved treatments for rare diseases.
article Official text account_balance Process page notifications_active Track this Bill
Status: Adopted
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_SRES_620
Sponsor: Sen. Barrasso, John [R-WY]
Process start date: 2026-02-26
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating February 28, 2026, as "Rare Disease Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_SRES_620.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2026-02-26.

What are the main provisions?

Key points include:

  • Designates February 28, 2026, as Rare Disease Day.
  • Promotes better awareness and earlier diagnosis for patients.
  • Supports national and global research for effective cures.
  • Highlights the need for more FDA-approved treatments for rare diseases.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Barrasso, John [R-WY].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S716; text: CR S711)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-02-28.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health